Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Healthy: early-phase trial registry
225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2 of 28,707 conditions by registered trial count.
1,096 US clinical trials · 225 currently recruiting · #2 of 28,707 conditions by registered trial count
Healthy: 1,096 US clinical trials tracked, 225 recruiting.
Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.
Enrollment posture brief
Registry condition healthy
OPEN 225 | RECR 21% | LATE 43 | EARLY 546 | RANK #2 | SPON 55
Volume-matched condition peers
Nearest open-share peer: Psoriasis (20% recruiting · 127 trials)
Healthy lists 225 open slots (21% of 1,096 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Healthy is recruiting below its size-band peers.
225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Healthy trials is spread across many organizations.
Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.
-
Most Healthy trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.
-
Healthy research is mostly interventional.
905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
1,096 total, page 12 of 22
The Effects of Intensity on Exercise-Induced Hypoalgesia During a Knee Extension Exercise
University of Central Florida
NCT05561582
A Study to Evaluate the Cardiac Safety of a Single Dose of AL-335 Administered on a Background of Simeprevir and Odalasvir and of Repeated Doses of Odalasvir Administered Alone in Healthy Participants
Janssen Research & Development
NCT03155893
Sleep, Circadian Rhythm & Skin Health
University Hospitals Cleveland Medical Center
NCT02457000
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
Healthpoint
NCT00645164
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Xemed
NCT01833390
Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers
Pfizer
NCT01101932
Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Allocation
Pennington Biomedical Research Center
NCT00287053
A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
Eli Lilly and Company
NCT06003465
Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg
Mylan Pharmaceuticals
NCT00650247
Bioequivalence of Two Transdermal Clonidine Administrations in Healthy Volunteers
Boehringer Ingelheim
NCT02096744
Assessing the Effects of a Cannabidiol Derived From Hemp Supplement in Healthy Adults
University of South Carolina
NCT05212402
Alternate Dosing Regimens of BG00012 in Healthy Volunteers
Biogen
NCT01281111
Study of the Safety, Tolerability, Pharmacokinetics and Pharmcodynamics of ILV-094 in Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer
NCT00447681
Lansoprazole 30 mg DR Capsule Fasting Study
Teva Pharmaceuticals U
NCT01045967
A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid Users
Alkermes
NCT02413281
Single Ascending Dose Study of TD-0714 in Healthy Subjects
Theravance Biopharma
NCT02639078
Single Ascending Dose PK, Oral Bioavailability and Food Effect Study in Healthy Male Volunteers
NewLink Genetics Corporation
NCT03852446
Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain
PATH
NCT02816346
Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg
Mylan Pharmaceuticals
NCT00648466
Comparison of Externally and Self-Initiated Movements
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00028197
Effects of Tucatinib on Cardiac Repolarization in Healthy Participants
Seagen
NCT03777761
Nicotine Patch, Blood Flow and Oxidative Stress Study
University of Pennsylvania
NCT00954096
Phase 1, Dose Escalation Study to Evaluate of Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy Volunteers
Pacira Pharmaceuticals
NCT05456490
Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg
Mylan Pharmaceuticals
NCT00650273
Demonstrate Bioequivalence Between 6 ? 2-mg Tablets of Perampanel and a Single 12-mg Tablet of Perampanel in Healthy Subjects
Eisai
NCT01396590
QT Intervals Study to Compare the Acute Effects of Orally Inhaled Dihydroergotamine (DHE), Oral Moxifloxacin, and Placebo
Allergan
NCT01191723
Trial of IW-1973 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers
Cyclerion Therapeutics
NCT02616861
Theta Burst Transcranial Magnetic Stimulation of Fronto-parietal Networks: Modulation by Mental State
University of Michigan
NCT04010461
Aqueous Humor Dynamics and Biometric Parameters in Eyes of Children
University of Nebraska
NCT01290588
Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers
Catabasis Pharmaceuticals
NCT01440166
Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Dose, on the QT/QTc Intervals in Healthy Subjects
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
NCT02508753
Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers
Currax Pharmaceuticals
NCT02353299
Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease
Pfizer
NCT04255875
PET Whole Body Imaging Using a Peripheral Benzodiazepine Receptor Ligand [C-11]PBR28
National Institute of Mental Health (NIMH)
NCT00407693
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Multiple Doses of TAK-831 in Healthy Participants
Neurocrine Biosciences
NCT03224325
Effects of Qigong, Tai Chi and Yoga Practice in Older Adults
Bastyr University
NCT00710853
Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers
Massachusetts General Hospital
NCT00934453
Effects of Instrument Assisted Soft Tissue Mobilization Regarding Range of Motion and Lower Extremity Power
Beth Marschner
NCT06610058
Multiple Dose Safety Study of SRX251 Capsules in Healthy Volunteers
Azevan Pharmaceuticals
NCT00532467
Effects of an Intermittent Fasting and Dietary Supplement Regimen on Glycemic Variability
Unicity International
NCT05493553
Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis
University at Buffalo
NCT02021162
A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects
Halozyme Therapeutics
NCT00311519
Immersive Virtual Reality Bicycling for Healthy Adults
Rutgers, The State University of New Jersey
NCT05253703
Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg
Mylan Pharmaceuticals
NCT00648622
A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
NCT06345794
The Effects of Hydromorphone on Responses to Verbal Tasks
University of Chicago
NCT02205983
Bioavailability of SC Formulation and Japanese Ethnobridging Study for PRA023
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
NCT05354349
A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers
Pfizer
NCT01637285
A Study to Evaluate the Relative Oral Bioavailability of Seltorexant (JNJ-42847922) After Administration of 3 Different Formulations in Healthy Participants Under Fasted and Semi-fasted Conditions
Janssen Research & Development
NCT03438461
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
Rockefeller University
NCT02018510
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 518 |
| Phase 2 | 28 |
| Phase 3 | 11 |
| Phase 4 | 32 |
Top Sponsors
Named interventions
Most-linked intervention names on Healthy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Healthy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Healthy page
1,096 registered trials, 225 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 225 Healthy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Eli Lilly and Company sponsors the most Healthy trials on record, review their full trial history before evaluating a specific study. See Eli Lilly and Company's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Healthy condition card totals 1,096 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.